Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,364 shares of the medical equipment provider’s stock after selling 172 shares during the period. CHICAGO TRUST Co NA’s holdings in Intuitive Surgical were worth $712,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Wealthspire Advisors LLC grew its holdings in shares of Intuitive Surgical by 10.9% during the 2nd quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock worth $509,000 after purchasing an additional 113 shares during the period. J.W. Cole Advisors Inc. boosted its stake in Intuitive Surgical by 37.2% during the second quarter. J.W. Cole Advisors Inc. now owns 2,767 shares of the medical equipment provider’s stock worth $1,231,000 after buying an additional 750 shares during the period. Brown Brothers Harriman & Co. increased its position in shares of Intuitive Surgical by 45.3% during the second quarter. Brown Brothers Harriman & Co. now owns 2,228 shares of the medical equipment provider’s stock valued at $991,000 after acquiring an additional 695 shares during the last quarter. Fairfield Financial Advisors LTD purchased a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $1,193,000. Finally, Angeles Investment Advisors LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $221,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $539.75 on Tuesday. The stock’s 50-day simple moving average is $536.58 and its 200-day simple moving average is $495.83. The firm has a market capitalization of $192.25 billion, a PE ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Citigroup raised their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.